Routine governance filing with no earnings or guidance content. Monitor for future equity grant activity under the expanded plan, but no near-term trading catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 20 $71.13entry
- T+1 · 6mo ago −1.94%α −2.13% · $69.75
- T+5 · 6mo ago +4.58%α +3.35% · $74.39
- T+20 · 5mo ago +13.96%α +13.22% · $81.06
- T+60 · 3mo ago +29.16%α +24.15% · $91.87
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Proto Labs held its 2026 annual meeting on May 19, 2026, where shareholders elected all seven director nominees, ratified Ernst & Young as auditor, approved executive compensation on an advisory basis, selected a one-year frequency for future say-on-pay votes, and approved an amendment to the 2022 Long-Term Incentive Plan increasing the share reserve by 395,000 shares. The plan amendment adds potential dilution of approximately 2.5% to the current share base, but the filing is a routine administrative report with no material financial information disclosed.
Key Facts
- Shareholders approved an additional 395,000 shares for the 2022 Long-Term Incentive Plan.
- All seven director nominees were elected with strong support (lowest vote share ~83% for Archie C. Black).
- Advisory vote on executive compensation passed with ~82% support.
- Frequency of future say-on-pay votes set to annual.
- Ratification of Ernst & Young as auditor passed with ~98% support.
- No departures, no C-suite changes, no financial results reported.
Financial Impact
Additional 395,000 shares authorized for equity awards represents ~2.5% dilution assuming ~15.5M shares outstanding, but no actual grants or issuance have occurred.
Risk Factors
- Potential future dilution as shares are granted under the expanded plan.
- Say-on-pay support at 82% is solid but not overwhelming, watch for proxy advisor concerns in future years.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001443669-26-000028 |
| Document: prlb-20260519.htm | 0001443669-26-000028 |
| Document: 0001443669-26-000028-index-headers.html | 0001443669-26-000028 |
| Document: 0001443669-26-000028-index.html | 0001443669-26-000028 |
| Document: 0001443669-26-000028.txt | 0001443669-26-000028 |
Track record
7 reports on PRLB
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +18.47% at T+5 after the Jul 31, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 4, 202612d ago Insider Buy Bullish 4/10 Entry $63.03 to $68.61 Now $65.15 +3.36% ▲ +8.85% +5.56% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $66.48 to $69.11 Now $65.15 −2.00% ▲ +3.96% +4.87% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $77.64 to $63.03 Now $65.15 −16.09% ▼ −18.82% −14.09% vs SPY
- Jul 31, 202615w ago 8-K Bullish 7/10 Entry $75.05 to $88.91 Now $65.15 −13.19% ▲ +18.47% +14.96% vs SPY
- May 20, 202625w ago 8-K Neutral 2/10 Viewing Entry $71.13 to $74.39 Now $65.15 −8.41% ▲ +4.58% +3.35% vs SPY
- May 7, 202627w ago 8-K Neutral 2/10 Entry $68.17 to $71.85 Now $65.15 −4.43% ▲ +5.40% +3.89% vs SPY
- Apr 8, 202631w ago DEFA14A Neutral 2/10 Entry $60.51 to $63.24 Now $65.15 +7.67% ▲ +4.51% +1.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers